Hospital Robots - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The hospital robots market size is projected to be USD 2.26 billion in 2025, USD 2.56 billion in 2026, and reach USD 5.01 billion by 2031, growing at a CAGR of 14.42% from 2026 to 2031. This report is Segmented by Product Type (Surgical, Rehabilitation, Service & Logistics, Disinfection, Telepresence, Pharmacy Automation), Application (Surgery, Rehabilitation, Logistics, Cleaning, Patient Engagement, Medication Dispensing), Component (Hardware, Software, Services), End User (General Hospitals, Specialty Hospitals, Ascs, and Others), and Geography. Market Forecasts are in Value (USD).

Global Hospital Robots Market Trends and Insights

Heightened Post-Pandemic Focus on Infection Control

Hospitals maintain UV-C disinfection budgets because automated cycles reduce pathogen loads in operating rooms and ICUs within minutes, trimming costly readmissions tied to surgical-site infections. LightStrike+ has completed over 35 million cycles and provides ISO 15883-compliant audit logs that simplify Joint Commission reviews. Facilities that adopted the platform during COVID-19 report persistent usage as bundled payments penalize hospital-acquired infections. The FDA 510(k) clearance reassures biomedical engineers that routine maintenance fits existing protocols. As capital budgets rebound, disinfection robots remain a visible first step toward wider hospital robots market deployment.

Rapid Adoption of Minimally Invasive Surgery

Intuitive Surgical’s da Vinci 5 adds force feedback and enhanced 3D vision, addressing earlier tactile gaps and enabling newly approved cardiac indications in 2026. Peer-reviewed studies still show mixed cost-outcome profiles, but faster patient recovery supports value-based contracts. Orthopedic programs mirror the trend; Stryker’s Mako platform surpassed 1.5 million knee and hip procedures in 2025, confirming scale potential when pathways standardize workflows. Together, these advances sustain double-digit growth for the hospital robots market as surgeons seek precision and patients demand smaller incisions.

High Capital Expenditure and ROI Concerns

Acquisition prices ranging from USD 1 million to USD 2.5 million deter hospitals operating on single-digit margins. A Baird survey found 77% of executives rank ROI validation as the top purchasing criterion, and 71% still rely on retained earnings for funding. Usage-based leases from Intuitive Surgical and Stryker reduce upfront cash but shift utilization risk to vendors. Absent distinct DRG codes, facilities bundle robotic costs into existing reimbursements, favoring high-volume centers and limiting near-term hospital robots market adoption among mid-tier providers.

Other drivers and restraints analyzed in the detailed report include:

• Shortage of Clinical Staff and Rising Labor Costs
• Integration of 5G-Enabled Telerobotics
• Complex Regulatory and Credentialing Pathways

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Surgical robots contributed 59.12% revenue in 2025, benefiting from an installed base of more than 8,000 da Vinci systems and accelerating orthopedic adoption driven by Mako’s 1.5 million procedures. Rehabilitation platforms are on track for 15.06% CAGR through 2031, fueled by aging demographics and payers that recognize cost savings from robotic gait therapy. This pocket outpaces the overall hospital robots market CAGR as stroke and spinal cord injury prevalence rise.

Price competition intensifies as Johnson & Johnson’s Ottava table-integrated design enters FDA review, promising reduced footprint costs. Service and logistics units such as Moxi and Aethon’s TUG diversify revenue by automating specimen, linen, and meal transport. Disinfection and telepresence robots remain niche yet strategic, anchoring infection prevention and remote consultation programs that feed the evolving hospital robots market.

Surgery retained 47.38% share in 2025 because robotic prostatectomy, hysterectomy, and colorectal resections command premium reimbursement. Rehabilitation, projected at 15.67% CAGR, gains traction as insurers accept outpatient exoskeleton therapy and home use following ReWalk 7 clearance in 2025.

Logistics-delivery volumes rise as pharmacy runs shift to Moxi, freeing nursing time and reducing medication turnaround intervals. Cleaning deployments persist post-pandemic as LightStrike+ supports infection-control metrics. Remote engagement remains modest yet expands coverage for dietetic and specialist consults. Together, these indications broaden the hospital robots market beyond the operating suite.

Complete Report Scope:

• By Product Type
  • Surgical Robots
  • Rehabilitation Robots
  • Service & Logistics Robots
  • Disinfection Robots
  • Telepresence Robots
  • Pharmacy Automation Robots
• By Application
  • Surgery
  • Rehabilitation
  • Logistics & Supply Delivery
  • Cleaning & Disinfection
  • Patient Engagement & Monitoring
  • Medication Dispensing
• By Component
  • Hardware
  • Software
  • Services
• By End User
  • General Hospitals
  • Specialty Hospitals
  • Ambulatory Surgical Centers
  • Rehabilitation Centers
  • Other End Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America contributed 38.83% revenue in 2025, underpinned by favorable reimbursement and a deep installed base. Saturation appears in large urban systems, so growth tilts toward ambulatory sites and community hospitals upgrading to compact systems. Canada trails the United States because provincial budgets limit capital purchases, while Mexico sees sporadic private installations.

Asia-Pacific advances at 16.14% CAGR through 2031, supported by China’s provincial grants that install surgical robots in tier-2 cities and Japan’s 5G teleoperation rollouts that bridge rural gaps. India’s private groups invest in da Vinci and Mako units to capture inbound medical tourism, lifting hospital robots market penetration.

Europe grows steadily despite longer approval cycles under MDR. Germany, France, and the United Kingdom lead deployments, whereas Southern and Eastern markets adopt at a slower rate. The Middle East and South America remain in the early stages but display strategic pilots in Gulf Cooperation Council hospitals and Brazilian academic centers that prove clinical worth and inform future scaling.

List of Companies Covered in this Report:

• ABB Ltd.
• Aethon Inc. (ST Engineering)
• Cyberdyne
• Diligent Robotics Inc.
• Ekso Bionics
• F&P Robotics AG
• Intuitive Surgical
• Johnson & Johnson
• KUKA AG
• Medtronic
• Omnicell
• Panasonic Corporation
• ReWalk Robotics
• Siemens Healthineers
• Smiths Group
• Stryker
• Swisslog Healthcare (KUKA AG)
• Xenex Disinfection Services Inc.
• Yaskawa Electric Corp.
• Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support